Suppr超能文献

血管生成素核酸酶活性的核糖体刺激检测

Assay for ribosome stimulation of angiogenin nuclease activity.

作者信息

Sholi Emily, Loveland Anna B, Korostelev Andrei A

机构信息

RNA Therapeutics Institute, UMass Chan Medical School, Plantation Street, Worcester, MA, United States.

RNA Therapeutics Institute, UMass Chan Medical School, Plantation Street, Worcester, MA, United States.

出版信息

Methods Enzymol. 2025;711:381-404. doi: 10.1016/bs.mie.2024.11.007. Epub 2024 Dec 4.

Abstract

Angiogenin (RNase 5) is an unusual member of the RNase A family with very weak RNase activity and a preference for tRNA. The tRNAs cleaved by angiogenin are thought to have a variety of roles in cellular processes including translation reprogramming, apoptosis, angiogenesis, and neuroprotection. We recently demonstrated that angiogenin is potently activated by the cytoplasmic 80S ribosome. Angiogenin's binding to the ribosome rearranges the C-terminus of the protein, opening the active site for the cleavage of tRNA delivered to the ribosomal A site which angiogenin occupies. Here, we describe the biochemical procedure to test angiogenin's activation by the ribosome using the assay termed the Ribosome Stimulated Angiogenin Nuclease Assay (RiSANA). RiSANA can be used to test the activity of wild-type or mutant angiogenin, or other RNases, against different tRNAs and with different ribosome complexes. For example, given that angiogenin has been implicated in anti-microbial activity, we tested the ability of bacterial 70S ribosomes to stimulate angiogenin activity and found that the E. coli ribosome does not stimulate angiogenin. We also assayed whether angiogenin's closest homolog, RNase 4, could be stimulated by the ribosome, but unlike angiogenin this enzyme was not further activated by the ribosome. The RiSANA assay promises to reveal new aspects of angiogenin mechanism and may aid in the development of new diagnostic tools and therapeutics.

摘要

血管生成素(核糖核酸酶5)是核糖核酸酶A家族中一个不同寻常的成员,其核糖核酸酶活性非常弱,且偏好于tRNA。血管生成素切割的tRNA被认为在包括翻译重编程、细胞凋亡、血管生成和神经保护等细胞过程中具有多种作用。我们最近证明,血管生成素可被细胞质80S核糖体有效激活。血管生成素与核糖体的结合会重新排列该蛋白质的C末端,为切割输送到血管生成素所占据的核糖体A位点的tRNA打开活性位点。在此,我们描述了一种生化方法,即使用称为核糖体刺激血管生成素核酸酶测定法(RiSANA)来检测核糖体对血管生成素的激活作用。RiSANA可用于测试野生型或突变型血管生成素或其他核糖核酸酶对不同tRNA以及不同核糖体复合物的活性。例如,鉴于血管生成素与抗菌活性有关,我们测试了细菌70S核糖体刺激血管生成素活性的能力,发现大肠杆菌核糖体不会刺激血管生成素。我们还检测了血管生成素最接近的同源物核糖核酸酶4是否能被核糖体刺激,但与血管生成素不同,这种酶不会被核糖体进一步激活。RiSANA测定法有望揭示血管生成素作用机制的新方面,并可能有助于开发新的诊断工具和治疗方法。

相似文献

1
Assay for ribosome stimulation of angiogenin nuclease activity.
Methods Enzymol. 2025;711:381-404. doi: 10.1016/bs.mie.2024.11.007. Epub 2024 Dec 4.
2
Structural mechanism of angiogenin activation by the ribosome.
Nature. 2024 Jun;630(8017):769-776. doi: 10.1038/s41586-024-07508-8. Epub 2024 May 8.
4
RNA digestion provides insights into the angiogenin's specificity towards transfer RNAs.
RNA Biol. 2021 Dec;18(12):2546-2555. doi: 10.1080/15476286.2021.1930758. Epub 2021 Jun 4.
6
Enzymatically active angiogenin/ribonuclease A hybrids formed by peptide interchange.
Biochemistry. 1988 Jan 12;27(1):219-26. doi: 10.1021/bi00401a033.
7
Stress induces tRNA cleavage by angiogenin in mammalian cells.
FEBS Lett. 2009 Jan 22;583(2):437-42. doi: 10.1016/j.febslet.2008.12.043. Epub 2008 Dec 27.
8
Angiogenin and tRNA fragments in Parkinson's disease and neurodegeneration.
Acta Pharmacol Sin. 2020 Apr;41(4):442-446. doi: 10.1038/s41401-020-0375-9. Epub 2020 Mar 6.
9
Angiogenin abolishes cell-free protein synthesis by specific ribonucleolytic inactivation of ribosomes.
Proc Natl Acad Sci U S A. 1987 Dec;84(23):8330-4. doi: 10.1073/pnas.84.23.8330.
10
RNA biology of angiogenin: Current state and perspectives.
RNA Biol. 2017 Feb;14(2):171-178. doi: 10.1080/15476286.2016.1272746.

本文引用的文献

1
mRNA-specific readthrough of nonsense codons by antisense oligonucleotides (R-ASOs).
Nucleic Acids Res. 2024 Aug 27;52(15):8687-8701. doi: 10.1093/nar/gkae624.
3
Structural mechanism of angiogenin activation by the ribosome.
Nature. 2024 Jun;630(8017):769-776. doi: 10.1038/s41586-024-07508-8. Epub 2024 May 8.
4
Angiogenin as a Possible Mediator of Macrophage-Mediated Regulation of Fibroblast Functions.
Bull Exp Biol Med. 2023 Sep;175(5):658-661. doi: 10.1007/s10517-023-05921-z. Epub 2023 Oct 20.
5
Human and mouse angiogenins: Emerging insights and potential opportunities.
Front Microbiol. 2022 Nov 17;13:1022945. doi: 10.3389/fmicb.2022.1022945. eCollection 2022.
6
The role of human ribonuclease A family in health and diseases: A systematic review.
iScience. 2022 Oct 7;25(11):105284. doi: 10.1016/j.isci.2022.105284. eCollection 2022 Nov 18.
7
Human RNase 4 improves mRNA sequence characterization by LC-MS/MS.
Nucleic Acids Res. 2022 Oct 14;50(18):e106. doi: 10.1093/nar/gkac632.
8
Ribosome inhibition by C9ORF72-ALS/FTD-associated poly-PR and poly-GR proteins revealed by cryo-EM.
Nat Commun. 2022 May 19;13(1):2776. doi: 10.1038/s41467-022-30418-0.
10
Angiogenin and Copper Crossing in Wound Healing.
Int J Mol Sci. 2021 Oct 2;22(19):10704. doi: 10.3390/ijms221910704.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验